APDN to Report Year End, FQ4’19 Q4 Financial Results
December 12th, 2019
Tag: Investor
Applied DNA Schedules Fiscal 2019 Fourth Quarter Financial Results Conference Call for Thursday, December 12, 2019 at 4:30 PM ET
December 5th, 2019
Applied DNA Sciences Regains Compliance with Nasdaq Listing Standards
November 25th, 2019
Applied DNA Sciences Announces Closing of Upsized $12.0 Million Underwritten Public Offering
November 15th, 2019
Applied DNA Sciences Announces Pricing of Upsized $12.0 Million Underwritten Public Offering
November 13th, 2019
Applied DNA Sciences Announces Appointment of Scott L. Anchin to Board of Directors
November 8th, 2019
Applied DNA Sciences Announces 1-For-40 Reverse Stock Split
October 31st, 2019
Applied DNA Receives Extension from Nasdaq
October 3rd, 2019
APDN Reports FY’19 Q3 Results
August 13th, 2019